Article

Global molecular landscape of early MASLD progression in obesity

2025-01-14

Abstract excerpt

<h4>Summary</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) is often asymptomatic early on but can progress to irreversible conditions like cirrhosis. Due to limited access to human liver biopsies, systematic and integrative molecular resources remain scarce. In this study, we performed transcriptomic analyses on liver and metabolomic analyses on liver and plasma samples from morbidly obese...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fbe6caac-c2bc-5000-916c-0eadc0faa84c
DOI: 10.1101/2025.01.13.632747

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Global molecular landscape of early MASLD progression in obesityDOI 10.1101/2025.01.13.632747Read

Sex-specific lipid-mediated mechanisms drive MASLD progression revealed by paired liver–blood multi-omicsSemantic proximity Read

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read

Metabolic Rewiring in MASLD: From Disease Mechanisms to Precision MedicineSemantic proximity Read

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity Read

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity Read

Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitisSemantic proximity Read

Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read

A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverSemantic proximity Read

Multi-omics profiling: the way toward precision medicine in metabolic diseasesSemantic proximity Read

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read